Evidence map›Paper›PMID 42640740›Full record

ArticleNeurosurgery2025

The Rationale for Early Adjuvant Radiotherapy After Gross Total Resection of Atypical Meningioma.

David R Raleigh, Charles Leland Rogers, Minesh P Mehta, William C Chen, Nancy Ann Oberheim Bush, Ramin A Morshed, Stephen T Magill, Philip V Theodosopoulos, Daniel P Cahill, Michael A Vogelbaum and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David R RaleighDepartment of Radiation Oncology, University of California, San Francisco, San Francisco, California, USA.
Charles Leland RogersRadiation Oncology, Utah Cancer Specialists, Salt Lake City, Utah, USA.
Minesh P MehtaDepartment of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, USA.
William C ChenDepartment of Radiation Oncology, University of California, San Francisco, San Francisco, California, USA.
Nancy Ann Oberheim BushDivision of Neuro-Oncology, University of California, San Francisco, San Francisco, California, USA.
Ramin A MorshedDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
Stephen T MagillDepartment of Neurological Surgery, Northwestern University, Chicago, Illinois, USA.
Philip V TheodosopoulosDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
Daniel P CahillDepartment of Neurological Surgery, Mass General Brigham, Boston, Massachusetts, USA.
Michael A VogelbaumDepartment of Neuro-Oncology, Moffit Cancer Center, Tampa, Florida, USA.
Michael W McDermottDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0001-7944-5181

Funding

Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4M
Understanding druggable drivers of meningioma tumorigenesisR01CA262311 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RALEIGH, DAVID R · 2021 to 2025
$2.7M
NCI NIH HHS P50 CA097257NCI NIH HHS R01 CA262311
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42640740
PMCPMC13507629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.